Decatur Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$12.3M |
| 2 |
Masco
MAS
|
+$12.1M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$12M |
| 4 |
Bread Financial
BFH
|
+$11.8M |
| 5 |
Campbell Soup
CPB
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$15.8M |
| 2 |
Paychex
PAYX
|
+$15.1M |
| 3 |
Boston Scientific
BSX
|
+$14M |
| 4 |
Estee Lauder
EL
|
+$13.9M |
| 5 |
CERN
Cerner Corp
CERN
|
+$12.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.39% |
| 2 | Technology | 16.63% |
| 3 | Communication Services | 12.95% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Industrials | 12.09% |
Similar funds
Decatur Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Decatur Capital Management held 124 positions worth $696M, down 13% from $798M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Decatur Capital Management withdrew a net $106M in Q4 2016, closing 23 positions and reducing 45 holdings. Its most notable exit was Intuitive Surgical, an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 22% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Decatur Capital Management opened a new position in Celgene Corp worth $12.8M.
- Decatur Capital Management's largest Q4 2016 buy was Celgene Corp: 110,875 shares worth $12.8M.
- Decatur Capital Management added most to Bread Financial in Q4 2016, an estimated $11.8M increase.
- Decatur Capital Management's biggest Q4 2016 reduction was Apple, cutting an estimated $4.04M.
- Decatur Capital Management fully exited Intuitive Surgical in Q4 2016, selling an estimated $15.8M.
- Decatur Capital Management's ten largest holdings make up 25% of its $696M portfolio in Q4 2016.
- Decatur Capital Management opened 30 new positions and closed 23 in Q4 2016.
- Decatur Capital Management's portfolio value fell 13% quarter-over-quarter to $696M.
Based on Decatur Capital Management's 13F filing for Q4 2016, filed 6 Feb 2017.